Does taking exogenous peptides shut down your body’s natural production?

It depends on which hormone system is involved. Giving growth hormone directly can temporarily reduce the body’s own GH secretion through negative feedback, and IGF-1 also participates in that control system. Human experiments have measured this suppression. That does not mean every peptide turns off an equivalent natural peptide, or that a temporary change proves permanent damage.[1][2]

GH-releasing peptides work differently from injecting GH: they stimulate an existing pituitary response. CJC-1295 and ipamorelin studies recorded increased endogenous GH release, but stimulation still takes place within a feedback-regulated system. “Your body makes it itself” therefore does not mean feedback, altered hormone exposure, or adverse effects are impossible. These short studies did not establish lifelong preservation of normal function after repeated use.[3][4]

The cited evidence does not establish the same predictable gonadal suppression pattern associated with testosterone treatment, nor does it prove that all secretagogue regimens are free of longer-term effects. Feeling worse after stopping could reflect loss of a drug effect or a pre-existing problem rather than newly created dependency. Persistent symptoms need clinical assessment; there is no evidence-based universal “post-cycle therapy” for peptides.[1][3][4]